IPSC: Century Therapeutics, Inc. Common Stock Company Profile & Statistics

About

Century Therapeutics Inc. is a cell therapy company. It involved in developing induced pluripotent stem cell -derived cell therapies in immuno-oncology. Century Therapeutics Inc. is based in PHILADELPHIA.

Info & Links

CEO

Brent Pfeiffenberger

Headquarters

25 N 38th Street, 11th Floor
PHILADELPHIA, PA 19104, UNITED STATES

Auditor

Ernst & Young LLP

Share holders

128

Employees

150

Century Therapeutics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

43.54M

Enterprise Value

-14.82M

Enterprise Value/EBITDA(ttm)

0.11

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

23.72

Price to Book(mrq)

0.32

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

-4480.37%

Profit Margin(ttm)

-3035.49%

Return on Equity(ttm)

-61.66%

Return on Invested Capital(ttm)

-68.13%

Return on Assets(ttm)

-31.78%

Income Statement

Revenue(ttm)

6.59M

Revenue Per Share(ttm)

0.08

Gross Profit(ttm)

6.59M

EBITDA(ttm)³

-129.65M

Net Income Available to Common(ttm)

-126.57M

Diluted EPS(ttm)

-1.85

Share Statistics

Beta (5Y Monthly)

1.73

52-Week Change

-80.95%

S&P 500 52-Week Change

6.35%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

86.05M

Dividend Yield

0.00%

Float⁴

79.25M

% Held by Insiders

6.80%

% Held by Institutions

50.20%

Balance Sheet

Total Cash(mrq)

189.29M

Total Cash Per Share(mrq)

2.20

Total Debt(mrq)

82.00K

Total Debt/Equity(mrq)

0.05%

Current Ratio(mrq)

1.50%

Quick Ratio(mrq)

10.39%

Book Value Per Share(mrq)

1.88

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.40

Free Cash Flow(ytd)

-110.29M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

IPSC

Century Therapeutics, Inc. Common Stock

Century Therapeutics, Inc. Common Stock Profile